NCT07181187View on ClinicalTrials.gov

Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

October 14, 2025

Study Completion Date

May 14, 2026

Conditions
Vitiligo
Interventions
DRUG

MH004 Ointment

MH004 1% ointment applied topically to the affected area as a thin film once or twice daily.

DRUG

Vehicle Ointment

Matching vehicle ointment applied topically to the affected area as a thin film once or twice daily.

Trial Locations (1)

Unknown

Hangzhou Third People's Hospital, Hangzhou

Sponsors
All Listed Sponsors
lead

Minghui Pharmaceutical (Hangzhou) Ltd

INDUSTRY

NCT07181187 - Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo | Biotech Hunter | Biotech Hunter